MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
Sort
Language
Type
Field
Venue
Topic
Cancer Genomics and Diagnostics
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

2,811 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
2,811 works in the cohort · of 4,299,418page 30 of 57

Labels cover 10 of 2,811 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 2,811 of 2,811 works in this cohort. Predictions are machine_predicted_unvalidated. The Gemma side is a direct model label for every work (title-only); the Codex side is a distilled, calibrated classifier. Candidate is the union; consensus is the intersection.

affunlabeled
Feasibility of circulating tumor DNA (ctDNA) to guide organ preservation in patients with node-negative rectal cancer undergoing neoadjuvant chemotherapy, excision, and observation in the phase II CCTG CO.28 trial.
Jonathan M. Loree, Russell W. Madison, Christopher J. O’Callaghan, Carl J. Brown, Dongsheng Tu, Derek J. Jonker +8 more
2023· article· en· Journal of Clinical Oncology· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
2
citations
affunlabeled
Tissue Dissociation for Metastasis Studies
Farhia Kabeer, Katrina Podsypanina
2016· article· en· Cold Spring Harbor Protocols· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
2
citations
affunlabeled
The co-evolution of the genome and epigenome in colorectal cancer
Andrea Sottoriva, Timon Heide, George D. Cresswell, Inma Spiteri, Claire Lynn, Javier Fernández-Mateos +23 more
2021· preprint· en· Research Square· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
2
citations
affunlabeled
Circulating tumor DNA (ctDNA) monitoring in participants (pts) with ovarian cancer treated with neoadjuvant pembrolizumab (pembro) + chemotherapy (chemo) ± anti–immunoglobulin-like transcript 4 (ILT4) monoclonal antibody MK-4830.
Jung‐Yun Lee, Carolina Ibáñez, Mariusz Bidziński, Ora Rosengarten, Emad Matanes, Victoria Mandilaras +14 more
2025· article· en· Journal of Clinical Oncology· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
2
citations
affunlabeled
Abstract CT188: BEHOLD-1: A Phase 1 Dose Escalation Study of GSK5733584, a B7-H4-Targeted Antibody-Drug Conjugate, in Patients With Advanced Solid Tumors, Including Dose Expansion in Patients With Endometrial and Platinum-Resistant Ovarian Cancer
William Bennion McKean, Philippe L. Bédard, Phuong Dinh, Toon Van Gorp, John Hilton, Katriina Jalkanen +15 more
2025· article· en· Cancer Research· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
2
citations
affunlabeled
Oncology in 2050 – A Retrospective?
Anthony M. Joshua, Ian F. Tannock
2020· article· en· The Oncologist· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
2
citations
affunlabeled
Clonal Hematopoiesis and COVID-19 Severity in Cancer Patients
Kelly L. Bolton, Michael B. Foote, Justin Jee, Anton Safonov, Ryan Ptashkin, Sean M. Devlin +13 more
2020· article· en· Blood· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
2
citations
affunlabeled
Imaging progression-free survival: How much does it matter to patients?
Jennifer O’Donnell, Andrew Robinson, Christopher M. Booth, Rachel Koven, Elizabeth A. Eisenhauer, Michael Brundage
2018· article· en· Journal of Clinical Oncology· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
2
citations

How this was built: Screen · Findings · About